NUVECTIS PHARMA INC (NVCT:NASDAQ)
$18.35 -0.64 (-3.3702%)
Analysed NUVECTIS PHARMA INC (NVCT:NASDAQ) News Sources
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
22-06-2026
yahoo.com
Nuvectis Expands Pipeline with Haisco Licensing Agreement for Two Clinical-Stage Drug Candidates (NVCT)
22-06-2026
advfn.com
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
23-06-2026
yahoo.com
Haisco and Nuvectis sign licensing deal for two drugs
24-06-2026
pharmaceutical-technology.com
What Makes Nuvectis Pharma (NVCT) a New Buy Stock
26-06-2026
yahoo.com
Nuvectis Pharma Announces Proposed Public Offering of Common Stock
29-06-2026
yahoo.com
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
30-06-2026
yahoo.com
Nuvectis Pharma shares slide after pricing $100 million discounted stock offering (NVCT)
30-06-2026
advfn.com
What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now?
01-07-2026
yahoo.com
Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
08-07-2026
yahoo.com
What is the current price of NUVECTIS PHARMA INC (NVCT:NASDAQ)?
The current price of NUVECTIS PHARMA INC (NVCT:NASDAQ) is $18.35.
NUVECTIS PHARMA INC (NVCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of NUVECTIS PHARMA INC (NVCT:NASDAQ) since the previous trading day is $-0.64.
NUVECTIS PHARMA INC (NVCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of NUVECTIS PHARMA INC (NVCT:NASDAQ) since the previous trading day is -3.3702%.
What is the most recent average sentiment score for NUVECTIS PHARMA INC (NVCT:NASDAQ)?
The most recent average sentiment score for NUVECTIS PHARMA INC (NVCT:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for NUVECTIS PHARMA INC (NVCT:NASDAQ)?
The most recent sentiment for NUVECTIS PHARMA INC (NVCT:NASDAQ) is .
SEC-8K** Filing Available For NUVECTIS PHARMA INC (NVCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.